Last reviewed · How we verify

CARNITINE — Competitive Intelligence Brief

CARNITINE (CARNITINE) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Carnitine Analog [EPC].

marketed Carnitine Analog [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

CARNITINE (CARNITINE).

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
CARNITINE TARGET CARNITINE marketed Carnitine Analog [EPC]
Carnitor LEVOCARNITINE Leadiant Biosci Inc marketed Carnitine Analog [EPC] Carnitine O-palmitoyltransferase 1, liver isoform 1985-01-01
L-carnitine L-carnitine Asan Medical Center marketed Carnitine Analog [EPC]
L-Ornithine ORNITHINE marketed Carnitine Analog [EPC] G-protein coupled receptor family C group 6 member A

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Carnitine Analog [EPC] class)

  1. · 2 drugs in this class
  2. Asan Medical Center · 1 drug in this class
  3. Leadiant Biosci Inc · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). CARNITINE — Competitive Intelligence Brief. https://druglandscape.com/ci/carnitine. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: